Weight Doctors® GLP-1 pharmacotherapyMedication-based, no procedure3–12 months · from €599Medically supervised pharmacotherapy with regular progress monitoring – with no procedure at all.
No procedure

Mon–Fri 8 am–8 pm · Sat 9 am–3 pm
Endoscopic stomach reduction and GLP-1 therapy together: what a 2024 study shows about the combination, how the SLEEVE procedures work and who this path may be an option for.

Medically reviewed byPriv.-Doz. Dr. med. Dörte WichmannSpecialist in visceral surgery & expert in endobariatricsLast updated:
As of today: This article dates from March 2025. Today, instead of GLP-1 support, the Extended Sleeve+ includes a hydroGMA; the current variants can be found on the SLEEVE page.
Obesity is one of the major health challenges of our time. It is far more than an aesthetic problem, because it carries serious health risks. Worldwide, over 650 million adults are affected (as of 2022), and the number continues to rise. Effective methods of weight reduction are therefore more in demand than ever.
Conventional approaches such as diets or individual treatments often show only limited success. A combination therapy of endoscopic stomach reduction and GLP-1 opens up new possibilities here.
Diets or exercise programmes often do not lead to lasting success: fewer than 10% of people can maintain their weight in the long term after a diet. The reasons are many:
Bariatric operations such as the gastric sleeve or the gastric bypass are effective, but come with higher risks and longer recovery times. Many people affected therefore look for a gentler yet still effective alternative.
A 2024 study shows that the combination of endoscopic stomach reduction (“EGR” in the study) and a drug therapy such as GLP-1 therapy achieved better results than either method alone.
The combination joins a minimally invasive stomach reduction with drug support: the Weight Doctors SLEEVE® together with GLP-1 therapy.
The basis is endoscopic bariatric and metabolic therapy (EBMT), an approach to sustainable weight reduction without a surgical incision. The SLEEVE procedure gently reduces the stomach volume and can thereby improve the natural feeling of fullness. Together with a GLP-1-based therapy, it can be an alternative to bariatric surgery – with lower risk and a shorter recovery time.

“Endoscopic procedures, that is, operations performed via a gastroscopy, offer the advantages of lower surgical trauma, lower risk and rapid convalescence (recovery) compared with classic surgical procedures (laparoscopic gastric sleeve). Until now, however, these advantages have come at the price of ultimately lower weight loss.”
With the Extended Sleeve plus, endoscopic stomach reduction was combined with GLP-1 therapy in 2025 in order to achieve treatment results close to those of a classic operation.
The study by Jirapinyo et al. (2024) examined the effectiveness of combination therapy between September 2017 and July 2022. 208 patients with obesity, or with a BMI of 27 or above and a weight-related condition such as high blood pressure, diabetes or hyperlipidaemia, were divided into three groups:
| Group | Weight loss after 12 months (TWL) |
|---|---|
| Combination therapy | 23,7 % |
| Monotherapy | 17,3 % |
| Sequential therapy | 12,0 % |
The percentage weight loss (“Total Weight Loss”) after 12 months was compared. In the combination group, all participants lost at least 10% of their body weight. The authors regard the combination of GLP-1 and endoscopic stomach reduction as a particularly effective non-surgical approach – best when both are combined within 6 months. Results vary from person to person.
Those who started GLP-1 therapy within six months of the endoscopic stomach reduction did best in the study. A later start led to weaker results – probably because the body had already settled into a new balance.
As with any medical treatment, there are limitations. In the study, people with previous bariatric operations, active alcohol consumption or smoking were excluded, as were people who had already taken part in similar studies.
Side effects included mild to moderate discomfort such as nausea or diarrhoea, which were mainly caused by the GLP-1 therapy. They usually occurred only in the first weeks and improved as treatment went on.
The Weight Doctors SLEEVE® is a minimally invasive method of stomach reduction. The decisive difference from an operation: it is performed endoscopically, that is, through the mouth. No incision is needed – no visible scars, no long recovery time.
Under general anaesthesia, the stomach wall is precisely folded and stitched so that the stomach takes on a tube-like shape. The stomach volume falls by up to 75% as a result – entirely without an incision. Unlike surgical stomach reduction, the stomach is fully preserved – nothing is removed. Many patients can go home the same or the next day and return to their everyday lives.
Weight Doctors® work with two endoscopic procedures. They differ in technique, but the aim is the same: to reduce the stomach volume gently and to strengthen the natural feeling of fullness.
All three variants use pose® 3.0 Double Helix or OverStitch NXT™, take around 30–60 minutes under anaesthesia and are outpatient procedures (stay approx. 4–5 hours); the Weight Doctors® App is included with each. They differ in how much the stomach is reduced:
Recommended BMI
Stomach reduction
Weight-loss goal
GLP-1 support (2025)
The weight-loss goal describes what the variant is intended for – not a promise. Results vary from person to person. The current variants and prices can be found on the Weight Doctors SLEEVE® page.
As with any operation, a stomach reduction also carries possible risks and complications:
GLP-1 (glucagon-like peptide-1) is a hormone produced by the body in the intestine that plays an important role in regulating appetite. This is how it works:
The therapy is given as a simple, regular injection and requires no surgical procedure. At Weight Doctors®, it is accompanied by a comprehensive preparation and aftercare programme – at the clinic and from home.
GLP-1 preparations were originally developed to treat diabetes and have also proved effective for weight loss. Common side effects are temporary nausea, digestive discomfort and, less often, headaches, which usually ease after the first weeks.
In the USA, at the time of the article, seven medications were approved for the treatment of obesity, including two GLP-1 receptor agonists. They work in different ways: they reduce the feeling of hunger via receptors in the brain, improve insulin sensitivity or lead to faster satiety. More about the therapy: Weight Doctors® GLP-1.

In the comparison, the combination achieved almost the same weight loss in the study as a stomach operation, with a lower procedural risk.
Weight loss
Invasive
Recovery time
Procedural risk
Source: Jirapinyo et al., 2024, and clinical comparison studies. Results vary from person to person.
An important advantage of combination therapy can be more sustainable weight loss. Whereas purely surgical methods often lead to hormonal adjustments that favour weight regain, drug support can help the body adapt better to the smaller stomach volume.
The treatment can also be adjusted individually: if a medication is not well tolerated, an alternative can be tried without reversing the endoscopic stomach reduction.
Are you looking for a long-term, safe and effective way to reduce your weight? Then the combination of endoscopic stomach reduction with the Weight Doctors SLEEVE® and GLP-1 therapy may be an option for you. Studies show that it can come close to the results of a surgical stomach reduction – with lower risk and a shorter recovery time.
The two methods complement each other: the SLEEVE creates the basis for smaller portions through the smaller stomach volume, while GLP-1 therapy additionally helps to control appetite and supports metabolism. Especially if you are struggling with severe excess weight and other methods have not helped, this combination can be a way forward.
Every body is different – which is why individual medical advice is essential to find the right treatment. As this form of therapy develops further, weight reduction is likely to become even more effective and safer in future. In a no-obligation consultation, we clarify whether this method suits your situation.




GLP-1 medications have changed the treatment of obesity. In the ENDO Podcast, Priv.-Doz. Dr. med. Dörte Wichmann explains the place endoscopic procedures have today – and what comes next.
1 min

Gastric sleeve, gastric bypass or Weight Doctors SLEEVE®: how the stomach reduction procedures work, how they differ and which option suits whom.
5 min

Never really full, constantly craving something sweet or lost your sense of measure? For every weight-loss type there is a suitable medical path – from the Weight Doctors SLEEVE® to GLP-1 therapy to the gastric balloon.
5 min
* For patients with German statutory health insurance: if the medical indication is established in line with the DGAV guidelines, reimbursement may be possible.
New treatments, dates such as our webinars and knowledge about losing weight – straight to your inbox. You can unsubscribe at any time with one click.
The first step is a conversation: choose your treatment, location and appointment online here – consultation on site, by video or by phone.
No matching treatment found. Select “Still undecided?” in one of the areas and we will call you.
* For patients with German statutory health insurance: if the medical indication is established in line with the DGAV guidelines, reimbursement may be possible.
Prefer to call? 0800 84 84 777Mon–Fri 8 am–8 pm · Sat 9 am–3 pm
Weight Doctors® at 23 locations in 6 countries23 locations
Which location is closest to you?
Which location is closest to you?
Germany
Austria
Netherlands
United Kingdom
South Africa
Namibia
Mira
Digital assistant from Weight Doctors®
With AI · Guidance, not medical advice. Privacy
Weight Doctors® GLP-1 pharmacotherapyMedication-based, no procedure3–12 months · from €599Medically supervised pharmacotherapy with regular progress monitoring – with no procedure at all.
No procedure
Weight Doctors® hydroGMAEndoscopic, no incisionsapprox. 30 min · on requestLosing weight without medication: lowering the hunger hormone endoscopically – no surgery, no incisions. On its own or combined with an endo sleeve.
Long-lastingNew
Weight Doctors® GASTRIC BALLOONTemporary, also swallowable6 or 12 months · from €3,490A temporary companion for 6 or 12 months – also swallowable, with no endoscopy at all.
No surgery
Weight Doctors SLEEVE®Endoscopic, permanent30–60 min · from €5,500Permanent stomach reduction without conventional surgery – endoscopic, outpatient, without scars.
No surgeryHealth insurance cover also possible*
Weight Doctors BARIATRICS®Surgical, minimally invasive1–3 nights · from €2,500Gastric bypass or gastric sleeve surgery for higher BMIs, incl. private medical preliminary examination and aftercare.
With surgeryHealth insurance cover also possible*
Weight Doctors® RESHAPEAfter weight lossindividual · from €1,950Post-bariatric body contouring after successful weight loss.
After weight lossHealth insurance cover also possible*
Weight Doctors® REVISIONCorrective procedure after weight-loss surgeryindividual · from €900Corrective procedure when earlier weight-loss surgery has not brought the desired success.
With surgeryHealth insurance cover also possible*
Weight Doctors® 360°Nutrition coachingper session · from €65Nutrition coaching and support in everyday life – in person, by video and in the app.
No procedure
Weight Doctors® MEMBERSHIPThe foundation of every therapyMedical oversight, app, scales, 3D Bodyscan and aftercare – the foundation of every Weight Doctors® therapy.
Weight Doctors® lipoedema surgeryLosing weight with a fat distribution disorder1.5–3 hours · from €950In lipoedema, fatty tissue increases abnormally on the legs or arms – with consultation and lipoedema surgery.
LipoedemaHealth insurance cover also possible*
* For patients with German statutory health insurance: if the medical indication is established in line with the DGAV guidelines, reimbursement may be possible.